Salvador
Martín Algarra
Consultor Médico
Netherlands Cancer Institute
Amsterda, HolandaPublikationen in Zusammenarbeit mit Forschern von Netherlands Cancer Institute (2)
2023
-
Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study
European Journal of Cancer, Vol. 190
2020
-
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Cancer Cell, Vol. 38, Núm. 4, pp. 500-515.e3